
Bioorganic and Medicinal Chemistry Letters p. 1519 - 1524 (1997)
Update date:2022-09-26
Topics:
Kohno, Yasushi
Awano, Katsuya
Miyashita, Mitsutomo
Ishizaki, Takayoshi
Kuriyama, Kazuhiko
Sakoe, Yasuhiko
Kudoh, Shinji
Saito, Koji
Kojima, Eisuke
A study of the structural optimization of tetrahydroquinoline-6-acetic acid and the development of a novel DMARD with prompt action are detailed. (S)-(+)-8-Chloro-1,2,3,4-tetrahydro-2-trifluoromethyl-6- quinolineacetic acid (IRA-378) exhibits the effect against both acute and chronic inflammations. It also has suppressive effects of bone destruction in adjuvant arthritis and Ca release from bones in vitro.
View MoreNanjing Legend Pharmaceutical & Chemical Co., Ltd.
Contact:+86-25-83767696
Address:14-7 Zhongshan Lu Guluo District, Nanjing
Hubei Onward Bio-Development Co., Ltd.
Contact:+86-718-8417012
Address:No.517,Shizhou Avenue,Enshi City,Hubei Province,China,445002
Disynthesis Chemical Technology Co. Ltd.
Contact:+86-571-88194596
Address:Dengyun road 380, Gongshu district, Hangzhou city, China
SJZ Chenghui Chemical Co., Ltd.
Contact:86-311-87713916
Address:no.368 youyi north avenue
Zhejiang Newfine Industry Co.,Ltd.
Contact:+86-573-82262042
Address:No.225,Dongqing Road, garoms@163.com
Doi:10.1021/jo00072a019
(1993)Doi:10.1248/cpb.41.772
(1993)Doi:10.1021/ol403133b
(2014)Doi:10.1021/jo00071a025
(1993)Doi:10.1021/ol403364k
(2014)Doi:10.1039/c3ob42275e
(2014)